A Controlled Study on Pain Management With Injection of Botulinum Toxin for Glabellar Line Correction

Injection Site Discomfort Clinical Trial

Official title:
An Open-label, Randomized, Split-face, Controlled Study on Pain Management With Injection of Botulinum Toxin for Glabellar Line Correction

Status Completed

Clinical Trial Summary

This is an open-label, single-center, randomized, split-face, controlled study to assess the effect of comfort intervention on pain during treatment injection compared against non-comfort intervention.

Clinical Trial Description

n/a

Study Design

Related Conditions & MeSH terms

Injection Site Discomfort

Clinical Trial Details

NCT number	NCT06161246
Study type	Interventional
Source	Galderma R&D
Contact
Status	Completed
Phase	Phase 4
Start date	October 23, 2023
Completion date	February 15, 2024

View Details

See also
Status	Clinical Trial	Phase
Recruiting	`NCT06011005` - Efficacy of Ethyl Chloride Topical Anesthesia Application on the Pain Perception During Intra-oral Injections in Children in Comparison to Benzocaine Gel.	N/A
Recruiting	`NCT05581433` - Vapocoolant Spray Application During Intraarticular Knee Injection	N/A
Not yet recruiting	`NCT05109000` - Comparison of Subcutaneous Injection of Normal Saline and Bacteriostatic Saline	Phase 4
Completed	`NCT04420559` - Intramuscular Benzathine Penicillin Injection Procedure	N/A
Recruiting	`NCT02497092` - Different Intravitreal Injection Techniques and Pain Level	N/A
Completed	`NCT02255604` - Effect of Intralymphatic Immunotherapy	Phase 2